MOBILITY DECREASED
Adverse reaction reported in 13,909 FDA reports across 8 drugs.
13,909
Total Reports
8
Drugs Involved
Natalizumab
Most Reported Drug
Drugs Associated with MOBILITY DECREASED
Drugs where "MOBILITY DECREASED" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Natalizumab | 3,835 | |
| 2 | Interferon Beta-1a | 3,696 | |
| 3 | Dalfampridine | 2,995 | |
| 4 | Caffeine | 933 | |
| 5 | Anakinra | 664 | |
| 6 | Oxazepam | 635 | |
| 7 | Hydroxide | 608 | |
| 8 | Quinapril | 543 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused mobility decreased. Always consult your healthcare provider.